Cantargia AB: insider trades · Finland · FIN-FSA FI:cantargia-ab SE0006371126 FI FI · FIN-FSA Mcap 843M€ Healthcare
Discover the full directors' dealings record of Cantargia AB, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Cantargia AB has recorded 5 reports. Market capitalisation: €842.8m. The latest transaction was disclosed on 26 March 2026 — Purchase. Among the most active insiders: David Liberg. The full history is free.
Financial data FY ended December 2025 · cache
Analyst consensus
2 analysts · 8.50 € Target 11.25 €(+232%) 14.00 €
Income statement
Revenue 316.7 M€
Net income 147.0 M€ 46.4% margin
Valuation
PER (trailing) 5.8x
PER (forward) -4.6x
P/Book 3.2x
Beta 1.65
Balance sheet & cash
Market cap 842.8 M€
Free Cash Flow 149.7 M€
Profitability & ownership
ROE 76.9%
ROA 41.3%
% insiders 17.0%
% institutions 27.2%
Last declaration on 26 March 2026
Declarations 5 total
Executives ● Purchase17 FIN-FSA
D
David Liberg Annan medlem i bolagets administrations-, lednings- eller kontrollorgan €4,926 13,000 shares @ €0.3789 0.0006% mcap 100.0% of flow SE0006371126⌘
Aktie
FI:A003X340-1 · 26 Mar 2026
Ideal exit: 21 Dec 2026 (T+270) Executives ● Purchase24 FIN-FSA
01,000,000 shares 0
Option
FI:A003R943-1 · 29 Aug 2025
Ideal exit: 26 May 2026 (T+270) Executives ● Purchase13 FIN-FSA
0250,000 shares 0
Option
FI:A003R861-1 · 29 Aug 2025
Ideal exit: 26 May 2026 (T+270) Executives ● Purchase9 FIN-FSA
D
David Liberg Annan medlem i bolagets administrations-, lednings- eller kontrollorgan 0250,000 shares 0
Option
FI:A003R856-1 · 29 Aug 2025
Ideal exit: 26 May 2026 (T+270) Executives ● Purchase21 FIN-FSA
0250,000 shares 0
Option
FI:A003R851-1 · 29 Aug 2025
Ideal exit: 26 May 2026 (T+270)